nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—Hypercholesterolaemia—Prednisone—ankylosing spondylitis	0.00439	0.00462	CcSEcCtD
Emtricitabine—DCK—Desoximetasone—Methylprednisolone—ankylosing spondylitis	0.00435	0.0885	CbGdCrCtD
Emtricitabine—Dermatitis bullous—Prednisolone—ankylosing spondylitis	0.00434	0.00457	CcSEcCtD
Emtricitabine—DCK—Desoximetasone—Betamethasone—ankylosing spondylitis	0.00428	0.0871	CbGdCrCtD
Emtricitabine—DCK—Desoximetasone—Dexamethasone—ankylosing spondylitis	0.00428	0.0871	CbGdCrCtD
Emtricitabine—DCK—Diflorasone—Methylprednisolone—ankylosing spondylitis	0.00422	0.0859	CbGdCrCtD
Emtricitabine—DCK—Desoximetasone—Triamcinolone—ankylosing spondylitis	0.00418	0.0851	CbGdCrCtD
Emtricitabine—DCK—Diflorasone—Betamethasone—ankylosing spondylitis	0.00415	0.0845	CbGdCrCtD
Emtricitabine—DCK—Diflorasone—Dexamethasone—ankylosing spondylitis	0.00415	0.0845	CbGdCrCtD
Emtricitabine—DCK—Diflorasone—Triamcinolone—ankylosing spondylitis	0.00406	0.0826	CbGdCrCtD
Emtricitabine—Dermatitis bullous—Triamcinolone—ankylosing spondylitis	0.00399	0.0042	CcSEcCtD
Emtricitabine—DCK—Desoximetasone—Prednisone—ankylosing spondylitis	0.00397	0.0808	CbGdCrCtD
Emtricitabine—Proteinuria—Methotrexate—ankylosing spondylitis	0.00395	0.00416	CcSEcCtD
Emtricitabine—Neuropathy—Prednisone—ankylosing spondylitis	0.0039	0.0041	CcSEcCtD
Emtricitabine—Protein urine present—Methotrexate—ankylosing spondylitis	0.0039	0.0041	CcSEcCtD
Emtricitabine—DCK—Desoximetasone—Prednisolone—ankylosing spondylitis	0.00387	0.0788	CbGdCrCtD
Emtricitabine—DCK—Diflorasone—Prednisone—ankylosing spondylitis	0.00385	0.0784	CbGdCrCtD
Emtricitabine—Skin discolouration—Methotrexate—ankylosing spondylitis	0.00384	0.00404	CcSEcCtD
Emtricitabine—Hyperbilirubinaemia—Methotrexate—ankylosing spondylitis	0.00382	0.00402	CcSEcCtD
Emtricitabine—DCK—Diflorasone—Prednisolone—ankylosing spondylitis	0.00376	0.0765	CbGdCrCtD
Emtricitabine—Muscular weakness—Prednisolone—ankylosing spondylitis	0.00366	0.00385	CcSEcCtD
Emtricitabine—Dermatitis bullous—Betamethasone—ankylosing spondylitis	0.00362	0.00381	CcSEcCtD
Emtricitabine—Dermatitis bullous—Dexamethasone—ankylosing spondylitis	0.00362	0.00381	CcSEcCtD
Emtricitabine—Inflammation—Methotrexate—ankylosing spondylitis	0.00358	0.00376	CcSEcCtD
Emtricitabine—Pancreatitis—Prednisolone—ankylosing spondylitis	0.00352	0.0037	CcSEcCtD
Emtricitabine—Breast disorder—Methylprednisolone—ankylosing spondylitis	0.00344	0.00362	CcSEcCtD
Emtricitabine—Muscular weakness—Triamcinolone—ankylosing spondylitis	0.00337	0.00354	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Methylprednisolone—ankylosing spondylitis	0.00336	0.00353	CcSEcCtD
Emtricitabine—Muscular weakness—Methylprednisolone—ankylosing spondylitis	0.00336	0.00353	CcSEcCtD
Emtricitabine—Pancreatitis—Triamcinolone—ankylosing spondylitis	0.00323	0.0034	CcSEcCtD
Emtricitabine—Pancreatitis—Methylprednisolone—ankylosing spondylitis	0.00323	0.00339	CcSEcCtD
Emtricitabine—Hypokalaemia—Betamethasone—ankylosing spondylitis	0.00315	0.00331	CcSEcCtD
Emtricitabine—Hypokalaemia—Dexamethasone—ankylosing spondylitis	0.00315	0.00331	CcSEcCtD
Emtricitabine—Urine output increased—Methotrexate—ankylosing spondylitis	0.00314	0.0033	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Prednisolone—ankylosing spondylitis	0.00314	0.0033	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Triamcinolone—ankylosing spondylitis	0.00307	0.00322	CcSEcCtD
Emtricitabine—Muscular weakness—Dexamethasone—ankylosing spondylitis	0.00305	0.00321	CcSEcCtD
Emtricitabine—Muscular weakness—Betamethasone—ankylosing spondylitis	0.00305	0.00321	CcSEcCtD
Emtricitabine—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.00293	0.00309	CcSEcCtD
Emtricitabine—Infestation—Methylprednisolone—ankylosing spondylitis	0.00293	0.00309	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Triamcinolone—ankylosing spondylitis	0.00288	0.00303	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Methylprednisolone—ankylosing spondylitis	0.00288	0.00303	CcSEcCtD
Emtricitabine—Polyuria—Methotrexate—ankylosing spondylitis	0.00287	0.00302	CcSEcCtD
Emtricitabine—Hypokalaemia—Prednisone—ankylosing spondylitis	0.00274	0.00289	CcSEcCtD
Emtricitabine—Renal failure acute—Methotrexate—ankylosing spondylitis	0.00273	0.00287	CcSEcCtD
Emtricitabine—Weight decreased—Dexamethasone—ankylosing spondylitis	0.00271	0.00285	CcSEcCtD
Emtricitabine—Weight decreased—Betamethasone—ankylosing spondylitis	0.00271	0.00285	CcSEcCtD
Emtricitabine—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.0027	0.00284	CcSEcCtD
Emtricitabine—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.0027	0.00284	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.00266	0.0028	CcSEcCtD
Emtricitabine—Muscular weakness—Prednisone—ankylosing spondylitis	0.00266	0.0028	CcSEcCtD
Emtricitabine—Rhinitis—Triamcinolone—ankylosing spondylitis	0.00265	0.00278	CcSEcCtD
Emtricitabine—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.00264	0.00278	CcSEcCtD
Emtricitabine—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.00262	0.00276	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.00262	0.00275	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.00262	0.00275	CcSEcCtD
Emtricitabine—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00259	0.00272	CcSEcCtD
Emtricitabine—Pancreatitis—Prednisone—ankylosing spondylitis	0.00256	0.00269	CcSEcCtD
Emtricitabine—Neutropenia—Prednisone—ankylosing spondylitis	0.00244	0.00256	CcSEcCtD
Emtricitabine—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00238	0.0025	CcSEcCtD
Emtricitabine—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00237	0.0025	CcSEcCtD
Emtricitabine—Weight decreased—Prednisone—ankylosing spondylitis	0.00236	0.00248	CcSEcCtD
Emtricitabine—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.00235	0.00247	CcSEcCtD
Emtricitabine—Depression—Prednisone—ankylosing spondylitis	0.00232	0.00244	CcSEcCtD
Emtricitabine—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00231	0.00243	CcSEcCtD
Emtricitabine—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00229	0.00241	CcSEcCtD
Emtricitabine—Angioedema—Prednisolone—ankylosing spondylitis	0.00228	0.0024	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.00228	0.0024	CcSEcCtD
Emtricitabine—Breast disorder—Methotrexate—ankylosing spondylitis	0.00228	0.0024	CcSEcCtD
Emtricitabine—Back pain—Triamcinolone—ankylosing spondylitis	0.00222	0.00234	CcSEcCtD
Emtricitabine—Pancreatitis—Methotrexate—ankylosing spondylitis	0.00214	0.00225	CcSEcCtD
Emtricitabine—Angioedema—Triamcinolone—ankylosing spondylitis	0.0021	0.00221	CcSEcCtD
Emtricitabine—Angioedema—Methylprednisolone—ankylosing spondylitis	0.0021	0.0022	CcSEcCtD
Emtricitabine—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00205	0.00216	CcSEcCtD
Emtricitabine—Neutropenia—Methotrexate—ankylosing spondylitis	0.00204	0.00214	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.00202	0.00213	CcSEcCtD
Emtricitabine—Cough—Triamcinolone—ankylosing spondylitis	0.00201	0.00211	CcSEcCtD
Emtricitabine—Myalgia—Triamcinolone—ankylosing spondylitis	0.00196	0.00206	CcSEcCtD
Emtricitabine—Pneumonia—Methotrexate—ankylosing spondylitis	0.00195	0.00205	CcSEcCtD
Emtricitabine—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00195	0.00205	CcSEcCtD
Emtricitabine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00195	0.00205	CcSEcCtD
Emtricitabine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00195	0.00205	CcSEcCtD
Emtricitabine—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00194	0.00204	CcSEcCtD
Emtricitabine—Infestation—Methotrexate—ankylosing spondylitis	0.00194	0.00204	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00194	0.00204	CcSEcCtD
Emtricitabine—Depression—Methotrexate—ankylosing spondylitis	0.00194	0.00204	CcSEcCtD
Emtricitabine—Renal failure—Methotrexate—ankylosing spondylitis	0.00191	0.00201	CcSEcCtD
Emtricitabine—Angioedema—Dexamethasone—ankylosing spondylitis	0.00191	0.002	CcSEcCtD
Emtricitabine—Angioedema—Betamethasone—ankylosing spondylitis	0.00191	0.002	CcSEcCtD
Emtricitabine—Immune system disorder—Prednisone—ankylosing spondylitis	0.00188	0.00198	CcSEcCtD
Emtricitabine—Infection—Triamcinolone—ankylosing spondylitis	0.00186	0.00196	CcSEcCtD
Emtricitabine—Infection—Methylprednisolone—ankylosing spondylitis	0.00186	0.00196	CcSEcCtD
Emtricitabine—Haematuria—Methotrexate—ankylosing spondylitis	0.00185	0.00195	CcSEcCtD
Emtricitabine—Insomnia—Prednisolone—ankylosing spondylitis	0.00184	0.00194	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00184	0.00193	CcSEcCtD
Emtricitabine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00184	0.00193	CcSEcCtD
Emtricitabine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00183	0.00193	CcSEcCtD
Emtricitabine—Mental disorder—Prednisone—ankylosing spondylitis	0.00183	0.00192	CcSEcCtD
Emtricitabine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00182	0.00191	CcSEcCtD
Emtricitabine—Malnutrition—Prednisone—ankylosing spondylitis	0.00182	0.00191	CcSEcCtD
Emtricitabine—Myalgia—Dexamethasone—ankylosing spondylitis	0.00178	0.00187	CcSEcCtD
Emtricitabine—Myalgia—Betamethasone—ankylosing spondylitis	0.00178	0.00187	CcSEcCtD
Emtricitabine—Anxiety—Betamethasone—ankylosing spondylitis	0.00177	0.00186	CcSEcCtD
Emtricitabine—Anxiety—Dexamethasone—ankylosing spondylitis	0.00177	0.00186	CcSEcCtD
Emtricitabine—Pain—Prednisolone—ankylosing spondylitis	0.00174	0.00183	CcSEcCtD
Emtricitabine—Hepatitis—Methotrexate—ankylosing spondylitis	0.00174	0.00183	CcSEcCtD
Emtricitabine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00173	0.00182	CcSEcCtD
Emtricitabine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00172	0.00181	CcSEcCtD
Emtricitabine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00171	0.0018	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00171	0.0018	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00171	0.00179	CcSEcCtD
Emtricitabine—Insomnia—Triamcinolone—ankylosing spondylitis	0.0017	0.00178	CcSEcCtD
Emtricitabine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00169	0.00178	CcSEcCtD
Emtricitabine—Infection—Dexamethasone—ankylosing spondylitis	0.00169	0.00178	CcSEcCtD
Emtricitabine—Infection—Betamethasone—ankylosing spondylitis	0.00169	0.00178	CcSEcCtD
Emtricitabine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00168	0.00177	CcSEcCtD
Emtricitabine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00168	0.00177	CcSEcCtD
Emtricitabine—Anaemia—Prednisone—ankylosing spondylitis	0.00168	0.00177	CcSEcCtD
Emtricitabine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00167	0.00176	CcSEcCtD
Emtricitabine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00167	0.00176	CcSEcCtD
Emtricitabine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00167	0.00176	CcSEcCtD
Emtricitabine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00167	0.00175	CcSEcCtD
Emtricitabine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00167	0.00175	CcSEcCtD
Emtricitabine—Angioedema—Prednisone—ankylosing spondylitis	0.00166	0.00175	CcSEcCtD
Emtricitabine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00165	0.00174	CcSEcCtD
Emtricitabine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00165	0.00173	CcSEcCtD
Emtricitabine—Urticaria—Prednisolone—ankylosing spondylitis	0.00162	0.0017	CcSEcCtD
Emtricitabine—Fatigue—Triamcinolone—ankylosing spondylitis	0.00162	0.0017	CcSEcCtD
Emtricitabine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00161	0.0017	CcSEcCtD
Emtricitabine—Pain—Triamcinolone—ankylosing spondylitis	0.0016	0.00169	CcSEcCtD
Emtricitabine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00157	0.00166	CcSEcCtD
Emtricitabine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00157	0.00165	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00155	0.00163	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00155	0.00163	CcSEcCtD
Emtricitabine—Myalgia—Prednisone—ankylosing spondylitis	0.00155	0.00163	CcSEcCtD
Emtricitabine—Arthralgia—Prednisone—ankylosing spondylitis	0.00155	0.00163	CcSEcCtD
Emtricitabine—Anxiety—Prednisone—ankylosing spondylitis	0.00154	0.00162	CcSEcCtD
Emtricitabine—Insomnia—Betamethasone—ankylosing spondylitis	0.00154	0.00162	CcSEcCtD
Emtricitabine—Insomnia—Dexamethasone—ankylosing spondylitis	0.00154	0.00162	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00154	0.00161	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00153	0.00161	CcSEcCtD
Emtricitabine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00153	0.00161	CcSEcCtD
Emtricitabine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00153	0.00161	CcSEcCtD
Emtricitabine—Mental disorder—Methotrexate—ankylosing spondylitis	0.00153	0.00161	CcSEcCtD
Emtricitabine—Malnutrition—Methotrexate—ankylosing spondylitis	0.00152	0.0016	CcSEcCtD
Emtricitabine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.0015	0.00158	CcSEcCtD
Emtricitabine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.0015	0.00158	CcSEcCtD
Emtricitabine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.0015	0.00158	CcSEcCtD
Emtricitabine—Urticaria—Triamcinolone—ankylosing spondylitis	0.00149	0.00157	CcSEcCtD
Emtricitabine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00149	0.00156	CcSEcCtD
Emtricitabine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00148	0.00156	CcSEcCtD
Emtricitabine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00148	0.00156	CcSEcCtD
Emtricitabine—Infection—Prednisone—ankylosing spondylitis	0.00147	0.00155	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00147	0.00155	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00147	0.00155	CcSEcCtD
Emtricitabine—Back pain—Methotrexate—ankylosing spondylitis	0.00147	0.00154	CcSEcCtD
Emtricitabine—Fatigue—Dexamethasone—ankylosing spondylitis	0.00147	0.00154	CcSEcCtD
Emtricitabine—Fatigue—Betamethasone—ankylosing spondylitis	0.00147	0.00154	CcSEcCtD
Emtricitabine—Pain—Betamethasone—ankylosing spondylitis	0.00146	0.00153	CcSEcCtD
Emtricitabine—Pain—Dexamethasone—ankylosing spondylitis	0.00146	0.00153	CcSEcCtD
Emtricitabine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00145	0.00153	CcSEcCtD
Emtricitabine—Skin disorder—Prednisone—ankylosing spondylitis	0.00144	0.00151	CcSEcCtD
Emtricitabine—Anaemia—Methotrexate—ankylosing spondylitis	0.0014	0.00148	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00139	0.00146	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00139	0.00146	CcSEcCtD
Emtricitabine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00138	0.00145	CcSEcCtD
Emtricitabine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00138	0.00145	CcSEcCtD
Emtricitabine—Urticaria—Dexamethasone—ankylosing spondylitis	0.00135	0.00142	CcSEcCtD
Emtricitabine—Urticaria—Betamethasone—ankylosing spondylitis	0.00135	0.00142	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00135	0.00142	CcSEcCtD
Emtricitabine—Dizziness—Prednisolone—ankylosing spondylitis	0.00135	0.00142	CcSEcCtD
Emtricitabine—Asthenia—Triamcinolone—ankylosing spondylitis	0.00135	0.00142	CcSEcCtD
Emtricitabine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00135	0.00142	CcSEcCtD
Emtricitabine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00135	0.00142	CcSEcCtD
Emtricitabine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00135	0.00142	CcSEcCtD
Emtricitabine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00135	0.00142	CcSEcCtD
Emtricitabine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00134	0.00141	CcSEcCtD
Emtricitabine—Insomnia—Prednisone—ankylosing spondylitis	0.00134	0.00141	CcSEcCtD
Emtricitabine—Paraesthesia—Prednisone—ankylosing spondylitis	0.00133	0.0014	CcSEcCtD
Emtricitabine—Pruritus—Triamcinolone—ankylosing spondylitis	0.00133	0.0014	CcSEcCtD
Emtricitabine—Cough—Methotrexate—ankylosing spondylitis	0.00132	0.00139	CcSEcCtD
Emtricitabine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00132	0.00139	CcSEcCtD
Emtricitabine—Dyspepsia—Prednisone—ankylosing spondylitis	0.0013	0.00137	CcSEcCtD
Emtricitabine—Arthralgia—Methotrexate—ankylosing spondylitis	0.00129	0.00136	CcSEcCtD
Emtricitabine—Myalgia—Methotrexate—ankylosing spondylitis	0.00129	0.00136	CcSEcCtD
Emtricitabine—Rash—Prednisolone—ankylosing spondylitis	0.00129	0.00135	CcSEcCtD
Emtricitabine—Dermatitis—Prednisolone—ankylosing spondylitis	0.00128	0.00135	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00128	0.00135	CcSEcCtD
Emtricitabine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00128	0.00135	CcSEcCtD
Emtricitabine—Fatigue—Prednisone—ankylosing spondylitis	0.00128	0.00134	CcSEcCtD
Emtricitabine—Headache—Prednisolone—ankylosing spondylitis	0.00128	0.00134	CcSEcCtD
Emtricitabine—Dizziness—Triamcinolone—ankylosing spondylitis	0.00124	0.0013	CcSEcCtD
Emtricitabine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00124	0.0013	CcSEcCtD
Emtricitabine—Infection—Methotrexate—ankylosing spondylitis	0.00123	0.00129	CcSEcCtD
Emtricitabine—Asthenia—Dexamethasone—ankylosing spondylitis	0.00122	0.00128	CcSEcCtD
Emtricitabine—Asthenia—Betamethasone—ankylosing spondylitis	0.00122	0.00128	CcSEcCtD
Emtricitabine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00121	0.00128	CcSEcCtD
Emtricitabine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00121	0.00128	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00121	0.00127	CcSEcCtD
Emtricitabine—Nausea—Prednisolone—ankylosing spondylitis	0.00121	0.00127	CcSEcCtD
Emtricitabine—Pruritus—Dexamethasone—ankylosing spondylitis	0.0012	0.00127	CcSEcCtD
Emtricitabine—Pruritus—Betamethasone—ankylosing spondylitis	0.0012	0.00127	CcSEcCtD
Emtricitabine—Skin disorder—Methotrexate—ankylosing spondylitis	0.0012	0.00127	CcSEcCtD
Emtricitabine—Vomiting—Triamcinolone—ankylosing spondylitis	0.00119	0.00125	CcSEcCtD
Emtricitabine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00119	0.00125	CcSEcCtD
Emtricitabine—Rash—Triamcinolone—ankylosing spondylitis	0.00118	0.00124	CcSEcCtD
Emtricitabine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00118	0.00124	CcSEcCtD
Emtricitabine—Rash—Methylprednisolone—ankylosing spondylitis	0.00118	0.00124	CcSEcCtD
Emtricitabine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00118	0.00124	CcSEcCtD
Emtricitabine—Urticaria—Prednisone—ankylosing spondylitis	0.00118	0.00124	CcSEcCtD
Emtricitabine—Headache—Triamcinolone—ankylosing spondylitis	0.00118	0.00124	CcSEcCtD
Emtricitabine—Headache—Methylprednisolone—ankylosing spondylitis	0.00117	0.00123	CcSEcCtD
Emtricitabine—Body temperature increased—Prednisone—ankylosing spondylitis	0.00117	0.00123	CcSEcCtD
Emtricitabine—Abdominal pain—Prednisone—ankylosing spondylitis	0.00117	0.00123	CcSEcCtD
Emtricitabine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00116	0.00122	CcSEcCtD
Emtricitabine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00116	0.00122	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00113	0.00119	CcSEcCtD
Emtricitabine—Dizziness—Dexamethasone—ankylosing spondylitis	0.00113	0.00118	CcSEcCtD
Emtricitabine—Dizziness—Betamethasone—ankylosing spondylitis	0.00113	0.00118	CcSEcCtD
Emtricitabine—Insomnia—Methotrexate—ankylosing spondylitis	0.00112	0.00118	CcSEcCtD
Emtricitabine—Nausea—Triamcinolone—ankylosing spondylitis	0.00111	0.00117	CcSEcCtD
Emtricitabine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00111	0.00117	CcSEcCtD
Emtricitabine—Nausea—Methylprednisolone—ankylosing spondylitis	0.00111	0.00117	CcSEcCtD
Emtricitabine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.0011	0.00116	CcSEcCtD
Emtricitabine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00109	0.00115	CcSEcCtD
Emtricitabine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00109	0.00115	CcSEcCtD
Emtricitabine—Vomiting—Betamethasone—ankylosing spondylitis	0.00108	0.00114	CcSEcCtD
Emtricitabine—Vomiting—Dexamethasone—ankylosing spondylitis	0.00108	0.00114	CcSEcCtD
Emtricitabine—Rash—Betamethasone—ankylosing spondylitis	0.00107	0.00113	CcSEcCtD
Emtricitabine—Rash—Dexamethasone—ankylosing spondylitis	0.00107	0.00113	CcSEcCtD
Emtricitabine—Dermatitis—Betamethasone—ankylosing spondylitis	0.00107	0.00113	CcSEcCtD
Emtricitabine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00107	0.00113	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00107	0.00112	CcSEcCtD
Emtricitabine—Fatigue—Methotrexate—ankylosing spondylitis	0.00107	0.00112	CcSEcCtD
Emtricitabine—Headache—Betamethasone—ankylosing spondylitis	0.00107	0.00112	CcSEcCtD
Emtricitabine—Headache—Dexamethasone—ankylosing spondylitis	0.00107	0.00112	CcSEcCtD
Emtricitabine—Asthenia—Prednisone—ankylosing spondylitis	0.00106	0.00112	CcSEcCtD
Emtricitabine—Pain—Methotrexate—ankylosing spondylitis	0.00106	0.00111	CcSEcCtD
Emtricitabine—Pruritus—Prednisone—ankylosing spondylitis	0.00105	0.0011	CcSEcCtD
Emtricitabine—Diarrhoea—Prednisone—ankylosing spondylitis	0.00101	0.00107	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00101	0.00107	CcSEcCtD
Emtricitabine—Nausea—Dexamethasone—ankylosing spondylitis	0.00101	0.00106	CcSEcCtD
Emtricitabine—Nausea—Betamethasone—ankylosing spondylitis	0.00101	0.00106	CcSEcCtD
Emtricitabine—Urticaria—Methotrexate—ankylosing spondylitis	0.000984	0.00103	CcSEcCtD
Emtricitabine—Dizziness—Prednisone—ankylosing spondylitis	0.00098	0.00103	CcSEcCtD
Emtricitabine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000979	0.00103	CcSEcCtD
Emtricitabine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000979	0.00103	CcSEcCtD
Emtricitabine—Vomiting—Prednisone—ankylosing spondylitis	0.000942	0.000991	CcSEcCtD
Emtricitabine—Rash—Prednisone—ankylosing spondylitis	0.000935	0.000983	CcSEcCtD
Emtricitabine—Dermatitis—Prednisone—ankylosing spondylitis	0.000934	0.000982	CcSEcCtD
Emtricitabine—Headache—Prednisone—ankylosing spondylitis	0.000929	0.000977	CcSEcCtD
Emtricitabine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000913	0.00096	CcSEcCtD
Emtricitabine—Asthenia—Methotrexate—ankylosing spondylitis	0.000889	0.000935	CcSEcCtD
Emtricitabine—Nausea—Prednisone—ankylosing spondylitis	0.00088	0.000926	CcSEcCtD
Emtricitabine—Pruritus—Methotrexate—ankylosing spondylitis	0.000876	0.000922	CcSEcCtD
Emtricitabine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000848	0.000891	CcSEcCtD
Emtricitabine—Dizziness—Methotrexate—ankylosing spondylitis	0.000819	0.000861	CcSEcCtD
Emtricitabine—Vomiting—Methotrexate—ankylosing spondylitis	0.000788	0.000828	CcSEcCtD
Emtricitabine—Rash—Methotrexate—ankylosing spondylitis	0.000781	0.000821	CcSEcCtD
Emtricitabine—Dermatitis—Methotrexate—ankylosing spondylitis	0.00078	0.000821	CcSEcCtD
Emtricitabine—Headache—Methotrexate—ankylosing spondylitis	0.000776	0.000816	CcSEcCtD
Emtricitabine—Nausea—Methotrexate—ankylosing spondylitis	0.000736	0.000774	CcSEcCtD
